Neuroblastoma Clinical Trials

• Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002634 - Active, not recruiting
  disseminated neuroblastoma; regional neuroblastoma; localized resectable neuroblastoma; recurrent neuroblastoma; localized unresectable neuroblastoma
  
• Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002802 - Active, not recruiting
  stage IVS neuroblastoma; disseminated neuroblastoma; localized unresectable neuroblastoma; regional neuroblastoma; localized resectable neuroblastoma
  
• Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002803 - Active, not recruiting
  stage IVS neuroblastoma; localized unresectable neuroblastoma; regional neuroblastoma; localized resectable neuroblastoma
  
• Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00003513 - Active, not recruiting
  regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; recurrent neuroblastoma; localized unresectable neuroblastoma
  
• Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy
  ClinicalTrials.gov Identifier: NCT00048386 - Active, not recruiting
  Neuroblastoma
  
• Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00025610 - Active, not recruiting
  disseminated neuroblastoma; stage 4S neuroblastoma
  
• Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00004110 - Active, not recruiting
  regional neuroblastoma; disseminated neuroblastoma; recurrent neuroblastoma; localized unresectable neuroblastoma
  
• Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00033293 - Recruiting
  localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma
  
• Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission
  ClinicalTrials.gov Identifier: NCT00002458 - Active, not recruiting
  recurrent neuroblastoma; disseminated neuroblastoma
  
• Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00005978 - Active, not recruiting
  localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; recurrent neuroblastoma; ...
  
• Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00017225 - Active, not recruiting
  localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; recurrent neuroblastoma; ...
  
• Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00025649 - Active, not recruiting
  localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma
  
• Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00072358 - Recruiting
  disseminated neuroblastoma; localized unresectable neuroblastoma; recurrent neuroblastoma; regional neuroblastoma; stage 4S neuroblastoma
  
• Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00026312 - Recruiting
  regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized resectable neuroblastoma; localized unresectable neuroblastoma
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002740 - Active, not recruiting
  disseminated neuroblastoma
  
• Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00003743 - Active, not recruiting
  disseminated neuroblastoma
  
• Multiple Therapies in Treating Patients With Advanced Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00040872 - Active, not recruiting
  regional neuroblastoma; disseminated neuroblastoma; recurrent neuroblastoma; localized unresectable neuroblastoma
  
• beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00037011 - Active, not recruiting
  disseminated neuroblastoma; recurrent neuroblastoma
  
• Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00093353 - Active, not recruiting
  Diarrhea; Drug Toxicity; disseminated neuroblastoma; recurrent neuroblastoma
  
• Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00006480 - Active, not recruiting
  disseminated neuroblastoma; Drug Toxicity; recurrent neuroblastoma
  
• CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00084422 - Recruiting
  recurrent neuroblastoma; disseminated neuroblastoma
  
• Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00025623 - Active, not recruiting
  disseminated neuroblastoma
  
• CHP677: I-Metaiodobenzylguanidine (I-MIBG) therapy for refractory neuroblastoma: a Phase II study
  ClinicalTrials.gov Identifier: NCT00013806 - Active, not recruiting
  Neuroblastoma
  
• Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00287950 - Active, not recruiting
  Neuroblastoma
  
• 131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00293319 - Active, not recruiting
  Neuroblastoma
  
• Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00276679 - Active, not recruiting
  Neuroblastoma
  
• ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00533169 - Active, not recruiting
  Neuroblastoma
  
• Melphalan and Buthionine Sulfoximine Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00005835 - Recruiting
  regional neuroblastoma; disseminated neuroblastoma; recurrent neuroblastoma; localized unresectable neuroblastoma
  
• Study On The Effectiveness Of Topotecan In Childhood Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00186849 - Active, not recruiting
  Neuroblastoma
  
• Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma.
  ClinicalTrials.gov Identifier: NCT00025597 - Active, not recruiting
  localized unresectable neuroblastoma
  
• Combination Chemotherapy in Treating Young Patients Who Are Undergoing Surgery and an Autologous Bone Marrow Transplant for Disseminated Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00365755 - Active, not recruiting
  Neuroblastoma
  
• Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only
  ClinicalTrials.gov Identifier: NCT00416559 - Active, not recruiting
  Long-Term Effects Secondary to Cancer Therapy in Children; Neuroblastoma
  
• Therapy for Children with Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00135135 - Recruiting
  Neoplasms; Neuroblastoma
  
• Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors
  ClinicalTrials.gov Identifier: NCT00003846 - Active, not recruiting
  disseminated neuroblastoma; untreated childhood supratentorial primitive neuroectodermal and pineal tumors; regional neuroblastoma; ...
  
• Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00417053 - Active, not recruiting
  Neuroblastoma
  
• Surgery in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00003122 - Recruiting
  localized resectable neuroblastoma; localized unresectable neuroblastoma
  
• Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00030719 - Recruiting
  regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma
  
• Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00025428 - Active, not recruiting
  localized unresectable neuroblastoma
  
• Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00276731 - Active, not recruiting
  Neuroblastoma
  
• Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00416676 - Active, not recruiting
  Neuroblastoma
  
• Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002748 - Active, not recruiting
  recurrent neuroblastoma
  
• Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas
  ClinicalTrials.gov Identifier: NCT00165139 - Active, not recruiting
  Neuroblastoma; Ewings Sarcoma; Non-Rhabdomyosarcoma Soft Tissue Sarcoma
  
• Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002560 - Active, not recruiting
  recurrent neuroblastoma
  
• Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients
  ClinicalTrials.gov Identifier: NCT00085930 - Recruiting
  Neuroblastoma
  
• Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement
  ClinicalTrials.gov Identifier: NCT00206388 - Recruiting
  Neuroblastoma
  
• Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00499616 - Recruiting
  Neuroblastoma
  
• Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00578864 - Recruiting
  Neuroblastoma
  
• Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions
  ClinicalTrials.gov Identifier: NCT00436696 - Recruiting
  Neuroblastoma
  
• Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00492167 - Recruiting
  Neuroblastoma
  
• ABT-751 in Treating Young Patients With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment
  ClinicalTrials.gov Identifier: NCT00436852 - Recruiting
  Neuroblastoma
  
• Safety Study of Nifurtimox for Relapsed or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00486564 - Recruiting
  Neuroblastoma
  
• Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00450827 - Recruiting
  Neuroblastoma
  
• Autologous Stem Cell Rescue With CD +133 Selected Cells in High-Risk Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00539500 - Recruiting
  Neuroblastoma
  
• Ethanol-Lock Treatment in Preventing Central Venous Catheter Infections in Patients With High-Risk Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00471679 - Recruiting
  Neuroblastoma
  
• Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00526318 - Recruiting
  Neuroblastoma
  
• Investigating the Use of Interleukin-12 and Interleukin-2 to Treat Children with Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00065494 - Recruiting
  Neuroblastoma
  
• Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00450307 - Recruiting
  Neuroblastoma
  
• Irinotecan, Vincristine, and Iodine I 131 Metaiodobenzylguanidine in Treating Young Patients With Resistant or Relapsed High-Risk Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00509353 - Recruiting
  Neuroblastoma
  
• Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00567567 - Recruiting
  Neuroblastoma
  
• Combination Chemotherapy in Treating Children With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00003093 - Completed
  regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma
  
• hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00082758 - Active, not recruiting
  recurrent neuroblastoma
  
• Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment
  ClinicalTrials.gov Identifier: NCT00089258 - Completed
  localized unresectable neuroblastoma; disseminated neuroblastoma; regional neuroblastoma; stage 4S neuroblastoma; recurrent neuroblastoma
  
• Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00024193 - Active, not recruiting
  stage 4S neuroblastoma
  
• Neuroblastoma Biology Studies
  ClinicalTrials.gov Identifier: NCT00256763 - Recruiting
  Neuroblastoma
  
• Vaccine Therapy in Treating Young Patients With Newly Diagnosed Metastatic or Recurrent Ewing Sarcoma Family of Tumors, Rhabdomyosarcoma, or Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00526240 - Recruiting
  Neuroblastoma; Sarcoma
  
• Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma.
  ClinicalTrials.gov Identifier: NCT00062855 - Completed
  Neuroblastoma
  
• Thalidomide and Temozolomide in Treating Young Patients With Relapsed or Progressive Brain Tumors or Recurrent Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00098865 - Active, not recruiting
  childhood brain tumor; childhood meningioma; childhood spinal cord tumors; Neuroblastoma
  
• Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors
  ClinicalTrials.gov Identifier: NCT00003750 - Active, not recruiting
  childhood soft tissue sarcoma; childhood solid tumor; Melanoma; Neuroblastoma; Osteosarcoma
  
• Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00101309 - Active, not recruiting
  recurrent neuroblastoma; recurrent tumors of the Ewing's family
  
• Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation in Treating Patients With Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00083135 - Active, not recruiting
  recurrent neuroblastoma
  
• Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00186862 - Completed
  Neuroblastoma
  
• Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00070200 - Completed
  recurrent neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma; localized resectable neuroblastoma; regional neuroblastoma; ...
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00017368 - Completed
  regional neuroblastoma; disseminated neuroblastoma; localized unresectable neuroblastoma; stage 4S neuroblastoma
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00004188 - Completed
  localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma
  
• Gene Therapy in Treating Children With Relapsed or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002713 - Completed
  recurrent neuroblastoma
  
• Chemotherapy in Treating Children With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002730 - Completed
  recurrent neuroblastoma
  
• Iodine I 131 Metaiodobenzylguanidine and Arsenic Trioxide in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
  ClinicalTrials.gov Identifier: NCT00107289 - Recruiting
  metastatic pheochromocytoma; recurrent pheochromocytoma; regional pheochromocytoma; recurrent neuroblastoma
  
• Surgery in Treating Children With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00003119 - Completed
  localized resectable neuroblastoma; stage 4S neuroblastoma
  
• Chemotherapy with Hematopoietic Stem Cell Support for Children with High Risk Solid Tumors and Lymphomas
  ClinicalTrials.gov Identifier: NCT00152126 - Active, not recruiting
  Neuroblastoma; Central Nervous System Tumors; Lymphomas; Wilms Tumor
  
• ZD1839 and Oral Irinotecan in Treating Young Patients with Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00132158 - Recruiting
  Glioblastoma; Rhabdomyosarcomas; Neuroblastoma; Osteosarcoma
  
• Fenretinide in Treating Children With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003191 - Active, not recruiting
  unspecified childhood solid tumor, protocol specific; recurrent neuroblastoma
  
• Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00202930 - Recruiting
  Neuroblastoma; Opsoclonus-Myoclonus
  
• High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00389766 - Not yet recruiting
  Brain and Central Nervous System Tumors
  
• P-glycoprotein Antagonist, Tariquidar, in Combination with Doxorubicin (Adriamycin), Vinorelbine (Navelbine), or Docetaxel to Treat Children with Solid Tumors
  ClinicalTrials.gov Identifier: NCT00011414 - Recruiting
  Brain Tumor; Ewing's Sarcoma; Neuroblastoma; Rhabdomyosarcoma
  
• Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00003737 - Completed
  recurrent neuroblastoma
  
• Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients
  ClinicalTrials.gov Identifier: NCT00082654 - Active, not recruiting
  Breast Cancer; Endocrine Cancer; female reproductive cancer; hematopoietic and lymphoid cancer; Neuroblastoma; psychosocial effects and treatment
  
• Docetaxel in Treating Children With Recurrent Solid Tumors
  ClinicalTrials.gov Identifier: NCT00002825 - Active, not recruiting
  recurrent childhood brain stem glioma; recurrent childhood rhabdomyosarcoma; recurrent neuroblastoma; recurrent childhood ependymoma; ...
  
• A Phase II Trial of All-Trans-Retinoic Acid in Combination with Interferon-Alpha 2a in Children with Recurrent Neuroblastoma or Wilms' Tumor
  ClinicalTrials.gov Identifier: NCT00001509 - Completed
  Nephroblastoma; Neuroblastoma
  
• Ixabepilone in Treating Young Patients With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00331643 - Active, not recruiting
  Kidney Cancer; Neuroblastoma; Sarcoma
  
• Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00003023 - Active, not recruiting
  childhood soft tissue sarcoma; Muscle Cancer; Neuroblastoma; Osteosarcoma
  
• Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood
  ClinicalTrials.gov Identifier: NCT00030667 - Active, not recruiting
  Ewing's family of tumors; childhood soft tissue sarcoma; Gastrointestinal Cancer; metastatic cancer; Neuroblastoma; Osteosarcoma
  
• Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00005576 - Completed
  disseminated neuroblastoma; regional neuroblastoma; recurrent neuroblastoma
  
• Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00053326 - Completed
  recurrent neuroblastoma
  
• Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor
  ClinicalTrials.gov Identifier: NCT00003273 - Active, not recruiting
  childhood brain tumor; childhood rhabdomyosarcoma; Neuroblastoma; Retinoblastoma
  
• Chemotherapy and Stem Cell Transplantation in Treating Children with Central Nervous System Cancer
  ClinicalTrials.gov Identifier: NCT00053118 - Active, not recruiting
  central nervous system cancer; childhood brain tumor; hematopoietic and lymphoid cancer; Neuroblastoma; Retinoblastoma
  
• New Therapeutic Strategies for Patients with Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00001335 - Completed
  Ewing's Sarcoma; Neuroblastoma; Rhabdomyosarcoma
  
• Alemtuzumab, Tacrolimus, and Methylprednisolone in Treating Acute Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00109993 - Active, not recruiting
  Breast Cancer; Endocrine Cancer; female reproductive cancer; Graft Versus Host Disease; hematopoietic and lymphoid cancer; Neuroblastoma
  
• Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00053950 - Completed
  recurrent neuroblastoma; disseminated neuroblastoma
  
• Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors
  ClinicalTrials.gov Identifier: NCT00281905 - Active, not recruiting
  Brain and Central Nervous System Tumors; Neuroblastoma
  
• Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00072488 - Recruiting
  Ewing's family of tumors; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; childhood rhabdomyosarcoma; Neuroblastoma